Marika Ciprotti

Nivolumab Plus Ipilimumab for Metastatic Castration-Resistant Prostate Cancer: Preliminary Analysis of Patients in the CheckMate 650 Trial

Padmanee Sharma, Russell K. Pachynski, Vivek Narayan et al. · Cancer Cell · 2020 · 393 citations · Full text

Medicine, Oncology, Pharmacology +15

Initial results from a phase II study of nivolumab (NIVO) plus ipilimumab (IPI) for the treatment of metastatic castration-resistant prostate cancer (mCRPC; CheckMate 650).

Padmanee Sharma, Russell K. Pachynski, Vivek Narayan et al. · Journal of Clinical Oncology · 2019 · 91 citations

Medicine, Oncology, Pharmacology +17

Phase I Imaging and Pharmacodynamic Trial of CS-1008 in Patients With Metastatic Colorectal Cancer

Marika Ciprotti, Niall C. Tebbutt, Fook-Thean Lee et al. · Journal of Clinical Oncology · 2015 · 37 citations · Full text

Medicine, Nuclear Medicine, Pharmacology +16

A Phase 1 and Biodistribution Study of ABT-806i, an ¹¹¹In-Radiolabeled Conjugate of the Tumor-Specific Anti-EGFR Antibody ABT-806

Hui Gan, Matthew Burge, Benjamin Solomon et al. · Journal of Nuclear Medicine · 2021 · 31 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

First clinical study of a pegylated diabody ¹²⁴I-labeled PEG-AVP0458 in patients with tumor-associated glycoprotein 72 positive cancers

Andrew M. Scott, Timothy Akhurst, Fook-Thean Lee et al. · Theranostics · 2020 · 25 citations · Full text

Medicine, Oncology, Pharmacokinetics +14